CCL2 influences the sensitivity of lung cancer A549 cells to docetaxel.

Wang, Ting; Zhan, Qingyuan; Peng, Xiaodong; Qiu, Zhimin; Zhao, Tiantian

Wang, Ting; Zhan, Qingyuan; Peng, Xiaodong; Qiu, Zhimin; Zhao, Tiantian.

Afiliación

Wang T; Department of Oncology, The People's Hospital of Nanchang County, Nanchang, Jiangxi 330200, P.R. China.
Zhan Q; Department of Internal Medicine 2, Tumor Hospital of Jiangxi Province, Nanchang, Jiangxi 330006, P.R. China.
Peng X; Department of Oncology, The First Affiliated Hospital of Nanchang University, Nanchang, Jiangxi 330006, P.R. China.
Qiu Z; Department of Internal Medicine 6, Tumor Hospital of Jiangxi Province, Nanchang, Jiangxi 330006, P.R. China.
Zhao T; Department of Respiratory Medicine, The First Affiliated Hospital of Nanchang University, Nanchang, Jiangxi 330006, P.R. China.

Oncol Lett ; 16(1): 1267-1274, 2018 Jul.

Article en En | MEDLINE | ID: mdl-30061946

Palabras clave

C-C motif chemokine ligand 2; docetaxel; lung cancer; phosphoinositide 3-kinase/protein kinase B signaling; viability

Texto completo

Añadir a Mi BVS

Imprimir

XML

PubMed Links

Buscar en Google

Texto completo: 1 Colección: 01-internacional Base de datos: MEDLINE Tipo de estudio: Diagnostic_studies Idioma: En Revista: Oncol Lett Año: 2018 Tipo del documento: Article Pais de publicación: Grecia

Texto completo

Añadir a Mi BVS

Imprimir

XML

PubMed Links

Buscar en Google